CY1115903T1 - Φλουρμπιπροφαινη και μυοχαλαρωτικοι συνδυασμοι - Google Patents

Φλουρμπιπροφαινη και μυοχαλαρωτικοι συνδυασμοι

Info

Publication number
CY1115903T1
CY1115903T1 CY20151100001T CY151100001T CY1115903T1 CY 1115903 T1 CY1115903 T1 CY 1115903T1 CY 20151100001 T CY20151100001 T CY 20151100001T CY 151100001 T CY151100001 T CY 151100001T CY 1115903 T1 CY1115903 T1 CY 1115903T1
Authority
CY
Cyprus
Prior art keywords
flurbiprophein
muscle related
related combinations
receptor agonist
combinations
Prior art date
Application number
CY20151100001T
Other languages
English (en)
Inventor
Ümit Cifter
Ali Türkyilmaz
Hasan Ali Turp
Original Assignee
Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi
Publication of CY1115903T1 publication Critical patent/CY1115903T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Η παρούσα εφεύρεση είναι μια νέα φαρμακευτική σύνθεση που περιλαμβάνει φλουρμπιπροφαίνη ή ένα φαρμακευτικά αποδεκτό άλας αυτής σε συνδυασμό με έναν αγωνιστή α-2 αδρενεργικών υποδοχέων ή έναν αγωνιστή υποδοχέων γ-αμινοβουτυρικού οξέος με αντιφλεγμονώδη, αναλγητική και μυοχαλαρωτική δράση.
CY20151100001T 2007-05-08 2015-01-02 Φλουρμπιπροφαινη και μυοχαλαρωτικοι συνδυασμοι CY1115903T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2007/03092A TR200703092A1 (tr) 2007-05-08 2007-05-08 Flurbiprofen ve kas gevşetici kombinasyonları
EP08103842.4A EP1992333B1 (en) 2007-05-08 2008-05-06 Flurbiprofen and muscle relaxant combinations

Publications (1)

Publication Number Publication Date
CY1115903T1 true CY1115903T1 (el) 2017-01-25

Family

ID=39032103

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100001T CY1115903T1 (el) 2007-05-08 2015-01-02 Φλουρμπιπροφαινη και μυοχαλαρωτικοι συνδυασμοι

Country Status (10)

Country Link
US (2) US8778391B2 (el)
EP (2) EP2805711A1 (el)
CY (1) CY1115903T1 (el)
DK (1) DK1992333T3 (el)
ES (1) ES2527344T3 (el)
HR (1) HRP20150002T1 (el)
PL (1) PL1992333T3 (el)
PT (1) PT1992333E (el)
SI (1) SI1992333T1 (el)
TR (1) TR200703092A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200708925A1 (tr) * 2007-12-26 2009-07-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Kontrollü salım sağlayan flurbiprofen ve kas gevşetici kombinasyonları
SG173071A1 (en) * 2009-01-22 2011-08-29 Sanofi Sa New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative
RU2493853C2 (ru) * 2009-01-22 2013-09-27 Санофи Новая комбинация активных ингредиентов, содержащая нестероидное противовоспалительное лекарственное средство и производное колхикозида
TR200907179A1 (tr) * 2009-09-18 2011-04-21 Sanovel İlaç San. Ve Ti̇c. A. Ş. Flurbiprofen ve kas gevşetici jel kombinasyonları
WO2011108006A2 (en) * 2010-03-02 2011-09-09 Lincoln Pharmaceuticals Limited A novel liquid oral spray dosage form comprising thiocolchicoside and anti-inflammatory agent
GB201010954D0 (en) * 2010-06-29 2010-08-11 Edko Pazarlama Tanitim Ticaret Compositions
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
WO2012173581A1 (en) 2011-03-21 2012-12-20 Ak Kimya Ithalat-Ihracat Ve Sanayii A.S. Thiocolchicoside, etodolac and famotidine combinations
TR201103752A2 (tr) 2011-04-18 2012-11-21 Ak Ki̇mya İthalat-İhracat Ve Sanayi̇i̇ A.Ş. Tiyokolşikozit, diklofenak ve lansoprazol kombinasyonları.
EP3197434A1 (en) * 2014-09-24 2017-08-02 Sanovel Ilac Sanayi ve Ticaret A.S. Loxoprofen and antispastic drug combinations
WO2023178183A1 (en) * 2022-03-16 2023-09-21 University Of Florida Research Foundation, Incorporated Combinatorial activation of gaba(b) and alpha-2 adrenergic receptors for treatment of stress induced depression

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205492A1 (en) * 1984-12-26 1986-12-30 SUNSHINE, Abraham Analgesic, anti-inflammatory and skeletal muscle relaxant compositions
HUT47849A (en) 1986-11-03 1989-04-28 Sandoz Ag Process for producing new pharmaceutical with analgetic and hypertonicity-relaxing effect
US5260337A (en) 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
AU5995094A (en) 1993-01-29 1994-08-15 Merck & Co., Inc. Ciclobenzaprine-caffeine combination as a muscle relaxant
FR2725134B1 (fr) 1994-10-04 1996-12-20 Lederle Lab Nouvelle association pharmaceutique a base d'ibuprofene et de thiocolchicoside
FR2735369B1 (fr) 1995-06-13 1997-07-11 Synthelabo Compositions pharmaceutiques a base de sel de sodium du diclofenac et de thiocolchicoside
WO1998052545A1 (en) * 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
WO2003029474A1 (fr) * 2001-09-27 2003-04-10 Dnavec Research Inc. Procede de regulation de l'expression d'un gene porte par un vecteur viral
US7074426B2 (en) * 2002-03-27 2006-07-11 Frank Kochinke Methods and drug delivery systems for the treatment of orofacial diseases
EP1740179A1 (en) * 2004-04-20 2007-01-10 Pfizer Limited Method of treating neuropathic pain using a crth2 receptor antagonist
ITBO20060313A1 (it) 2006-04-26 2007-10-27 Alma Mater Studiorum Uni Di Bologna Formulazioni farmaceutiche per uso transdermico
MX2009006114A (es) 2007-03-02 2009-11-10 Meda Pharmaceuticals Inc Composiciones que comprenden carisoprodol y metodos de uso de las mismas.

Also Published As

Publication number Publication date
HRP20150002T1 (hr) 2015-03-27
US8778391B2 (en) 2014-07-15
ES2527344T3 (es) 2015-01-22
US20080279933A1 (en) 2008-11-13
US20140308348A1 (en) 2014-10-16
PL1992333T3 (pl) 2015-04-30
SI1992333T1 (sl) 2015-02-27
EP2805711A1 (en) 2014-11-26
TR200703092A1 (tr) 2008-12-22
PT1992333E (pt) 2015-01-14
EP1992333B1 (en) 2014-10-08
EP1992333A1 (en) 2008-11-19
DK1992333T3 (en) 2015-01-12

Similar Documents

Publication Publication Date Title
CY1115903T1 (el) Φλουρμπιπροφαινη και μυοχαλαρωτικοι συνδυασμοι
CY1112474T1 (el) Πιπεριδινικοι gpcr αγωνιστες
CY1120417T1 (el) Μεθοδοι για τη μειωση των επιπεδων των βασεοφιλων
CY1116163T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει εναν glp-1-αγωνιστη, μια ινσουλινη, και μεθειονινη
EA201070786A1 (ru) Бензофуропиримидиноны
CY1120297T1 (el) Ρυθμιστες υποδοχεα ανδρογονου και χρησεις αυτων
CY1115004T1 (el) Φαρμακευτικοι συνδυασμοι ενος ανταγωνιστη υποδοχεων αγγειοτασινης και ενος αναστολεα νερ
CY1121853T1 (el) Συνδυαστικη θεραπεια για την αγωγη του διαβητη
CY1121043T1 (el) Θεραπευτικες ενωσεις
CY1113352T1 (el) Ενωση σπειρο-δακτυλιου και χρηση αυτης για ιατρικους σκοπους
EA200900796A1 (ru) Пиперидиновые агонисты gpcr
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
CY1118396T1 (el) Θερμοπητικες αναισθητικες συνθεσεις
CY1120089T1 (el) Παραγωγα ουριας ή φαρμακολογικως αποδεκτα αλατα εξ' αυτων χρησιμα ως αγωνιστες του παρομοιου με υποδοχεα πεπτιδιου φορμυλιου 1(fprl-1)
EA200900879A1 (ru) Пиперидиновые агонисты gpcr
CY1115087T1 (el) Παραγωγα αμινο-πυριδινων ως αγωνιστες των υποδοχεων s1p1/edg1
BRPI0809366A8 (pt) polipeptídeos interligados
CL2007002167A1 (es) Compuestos derivados de indol, antagonistas iap; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de cancer.
CY1121881T1 (el) Φαρμακοτεχνικη μορφη που περιεχει σταθερη αναλογια ινσουλινης glargine/λιξισενατιδης
EA201100306A1 (ru) Производные циклогексиламида и их применение в качестве антагонистов рецептора crf-1
CY1117004T1 (el) Παραγωγο τετραϋδροϊσοκινολιν-1-ονης ή αλας εξ' αυτου
CY1114089T1 (el) Μακροχρονια θεραπεια της μολυνσης απο hiv με tcm278
CY1119560T1 (el) Μεθοδοι για μειωση αδηφαγικης διαταραχης ή ψυχαναγκαστικης υπερφαγιας
CY1113341T1 (el) Ρυθμιστες υποδοχεα ανδρογονου τετραϋδροκυκλοπεντα[β]ινδολιο
ECSP099442A (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona